Fridays Semaglutide: How the Program Sources and Prescribes It

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

What follows is independent editorial coverage. PlexusDx holds no commercial ties to Fridays or its parent company, and nothing here is an affiliate placement or paid arrangement.

Full head-to-head: PlexusDx vs Fridays →

Because "Fridays semaglutide" is a common search, this review isolates one question: how does Fridays handle the semaglutide molecule specifically? Semaglutide is the GLP-1 receptor agonist behind much of the current weight-management conversation, and telehealth brands like Fridays each route it differently. Written as fair-balance context, not a purchase recommendation. As of April 2026.

How Fridays approaches semaglutide

Fridays (Fridays Health) runs on a telehealth-plus-compounded-pharmacy model. For semaglutide, that generally means a virtual intake, a licensed clinician's review, and — where eligibility is met — a prescription routed to either a retail pharmacy for an FDA-approved brand or a 503A compounding pharmacy for compounded semaglutide. Confirm the current structure on Fridays's official website.

The semaglutide intake path

The sequence most brands share applies here too: a patient submits weight, medical history, and a medication list; a clinician confirms eligibility and issues the script; fulfillment moves to the chosen pharmacy; and follow-up visits support titration and side-effect management. What varies between programs is provider type, pharmacy partner, and how the subscription is billed.

Compounded semaglutide versus the branded product

The word "semaglutide" covers two supply routes. FDA-approved branded semaglutide is manufactured and dispensed through retail pharmacies, while compounded semaglutide is prepared by a 503A compounding pharmacy against an individual prescription. Compounded preparations are not FDA-approved products and are not interchangeable with branded ones; which route a given Fridays plan uses is disclosed on the brand's own pages.

What semaglutide does inside the body

Semaglutide is a GLP-1 receptor agonist — the same mechanistic class as liraglutide and dulaglutide, and distinct from the GIP/GLP-1 dual agonist tirzepatide. Its evidence base includes the STEP program for weight management, published in The New England Journal of Medicine in 2021. Trial populations and endpoints differ from real-world use, and individual outcomes vary.

Fridays semaglutide pricing at a glance

Fridays publishes its rates on its own site. As of its pricing page (joinfridays.com/pricing, verified 2026-07-20), Fridays advertises compounded semaglutide at $249/mo as an ongoing month-to-month rate, with $0 membership, free shipping, and coaching and dietitian support included; a paid-annually plan works out to roughly $150/mo. Fridays' rates moved materially within a single day. For context, PlexusDx's month-to-month rate runs roughly $60–$70/mo below Fridays' advertised month-to-month, and Fridays also sells prepaid bundles. Verify current figures at Fridays's official website before committing — numbers change frequently.

The genetic layer Fridays leaves out

A semaglutide prescription, no matter how it is dispensed, does not read your underlying metabolic biology. Variants in FTO (the fat-mass and obesity-associated gene), GLP1R (the GLP-1 receptor gene, the direct target of semaglutide), MC4R (a melanocortin receptor central to satiety), and TCF7L2 (a transcription factor tied to glucose homeostasis and GLP-1 secretion) describe the terrain the molecule acts on. These are pathway-level markers: they do not predict how you will respond to semaglutide, but they map the biology a clinician is prescribing into.

Before starting any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including FTO, MC4R, and TCF7L2 variants that shape baseline appetite-regulation and energy-balance biology. That is the test before you invest idea: converting guesswork into an informed conversation with your provider.

Where PlexusDx fits for semaglutide

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — including Semaglutide Injection and Semaglutide Oral, alongside Tirzepatide Injection and Tirzepatide Oral. The distinguishing element is upstream genetic context rather than the script alone.

Not affiliated: PlexusDx is not affiliated with Fridays and has no commercial relationship with the companies reviewed in this article.

Related reading on PlexusDx: Wegovy 24 Mg, Wegovy Diet, Wegovy Website, Wegovy Cash Price.

Disclaimer: This article is educational. PlexusDx is not affiliated with Fridays and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols — this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Frequently Asked Questions

Does Fridays offer compounded or branded semaglutide?

Fridays operates a telehealth-plus-compounded-pharmacy model, so semaglutide may be routed as an FDA-approved brand through a retail pharmacy or as compounded semaglutide through a 503A pharmacy. Which route applies depends on the plan and eligibility, disclosed on the brand's own site. Verify before purchase.

How is compounded semaglutide different from the branded version?

Branded semaglutide is an FDA-approved manufactured product dispensed at retail pharmacies. Compounded semaglutide is prepared by a 503A pharmacy against an individual prescription and is not an FDA-approved product. The two are not interchangeable, and a clinician determines which is appropriate for a given patient.

Can a genetic test tell me if semaglutide will work for me?

No. The Precision Peptide Genetic Test does not predict response to semaglutide or any compound. It analyzes pathway-level variants in FTO and MC4R, and TCF7L2 that describe baseline GLP-1 biology — upstream context that applies regardless of which program prescribes semaglutide.

How does PlexusDx semaglutide compare to Fridays?

PlexusDx offers semaglutide through its Weight Management Protocols paired with the Precision Peptide Genetic Test for genetic context. Its month-to-month rate runs roughly $60–$70/mo below Fridays' advertised month-to-month, and Fridays also sells prepaid multi-month bundles. The differentiator is pathway-level insight.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.